Keep Factually independent
Whether you agree or disagree with our analysis, these conversations matter for democracy. We don't take money from political groups - even a $5 donation helps us keep it that way.
Who founded NeurOcept and when was it established?
Executive summary
Available public filings show a UK company named NEUROCEPT LIMITED was incorporated on 20 November 2015 (company number 09882135) and later dissolved on 25 April 2017 [1]. Contemporary U.S. product pages and press releases for a dietary supplement called “Neurocept” or “Neurocept™” present marketing copy and a November 7, 2025 launch/press distribution, but those pages do not clearly identify a single founder or a firm founding date for the marketed supplement [2] [3].
1. Corporate record: a UK company with a clear incorporation date
A direct company-record source, GOV.UK’s Companies House lookup, lists NEUROCEPT LIMITED (company number 09882135) as incorporated on 20 November 2015 and later dissolved on 25 April 2017 [1]. That entry provides a precise legal formation date and a registered office address in Birmingham, England, which makes it the most authoritative public-record timestamp among the supplied materials [1]. The filing does not, in the extracts provided, name an individual “founder” in the sense of a public CEO or sole proprietor in promotional materials [1].
2. Consumer-facing Neurocept product pages: marketing, not corporate history
Multiple websites using the Neurocept name offer supplement product claims, ingredient lists, and marketing material but do not give a verifiable founder’s name or a formal “established” company date for the product in the excerpts shown [2] [4] [5]. For example, Neurocept’s U.S. official site describes the formula, manufacturing claims and suggested use but contains no clear corporate founding statement or named founder in the provided snippets [2] [4]. These pages function as product marketing rather than legal-company disclosures [2] [4].
3. Press and publicity: 2025 launch language, but not a founder identity
Press-distributed pieces and syndications dated Nov. 7, 2025, repeatedly describe Neurocept as a newly spotlighted cognitive supplement entering the U.S. market—language consistent with a product launch or publicity push [3] [6] [7]. These items report the date of market entrance but do not identify who founded the brand or the corporate entity behind the product in the quoted passages [3] [6]. A press release-style article therefore supplies a public launch timestamp but not founding-person details [3].
4. Conflicting or problematic signals in consumer reviews and scam reports
Consumer reviews and complaint trackers suggest there may be deceptive marketing around some Neurocept products—reviews allege use of celebrity likenesses, ingredient misrepresentation, and concerns about scams, and a BBB scam report documents a purchase in September 2025 [8] [9]. Those sources raise reliability and provenance questions about some Neurocept-branded offerings but do not directly address who originally founded the product line [8] [9].
5. Two distinct layers — a legal entity and a marketed supplement — require careful separation
The supplied materials point to two separate things you could reasonably mean by “who founded NeurOcept”: (A) a legal UK company called NEUROCEPT LIMITED incorporated 20 November 2015 [1], or (B) a marketed dietary-supplement brand called Neurocept/Neurocept™ promoted in 2025, which has public-facing sites and press releases but no clear founder attribution in the excerpts [2] [3]. Available sources do not mention a named individual founder for the supplement brand in the provided pages [2] [3] [1].
6. What is and isn’t supported by the current reporting
- Supported: NEUROCEPT LIMITED (UK) was incorporated 20 November 2015 and dissolved 25 April 2017 [1].
- Supported: Multiple Neurocept product sites and Nov. 7, 2025 press items present the supplement as newly promoted to the U.S. market [2] [3].
- Not found in current reporting: a clear, consistent founder name or an explicit founding date for the marketed U.S. Neurocept supplement across the supplied sources [2] [3] [1].
7. How to follow up to get a definitive founder attribution
To pin down a founder name you should consult: (a) company incorporation records for the entity selling the U.S. supplement (U.S. state business registries or an on-site corporate disclosures page), (b) archived WHOIS or “About” pages for the various Neurocept domains, and (c) press filings, SEC/advertising-disclosure documents or direct contact with the vendor. Those steps are not covered in the supplied sources—available sources do not mention those next-step records in the excerpts provided [2] [1] [3].
Summary conclusion: The only clean founding date in the supplied material is the UK company incorporation on 20 November 2015 [1]. The contemporary supplement marketed as Neurocept has a visible 2025 launch narrative but the provided sources do not identify who founded that product [3] [2].